Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Female Osteoporosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00191893
What this trial is testing

Bone Effects of Teriparatide Following Alendronate

Who this might be right for
Osteoporosis
Eli Lilly and Company 66
Not applicableStudy completedNCT01049191
What this trial is testing

Bone Microarchitecture in Women With and Without Fracture

Who this might be right for
OsteoporosisFracture
University of Wisconsin, Madison 78
Large-scale testing (Phase 3)Study completedNCT00022087
What this trial is testing

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Who this might be right for
Breast CancerOsteoporosis
Alliance for Clinical Trials in Oncology 439
Testing effectiveness (Phase 2)Study completedNCT00165204
What this trial is testing

Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy

Who this might be right for
MenopausePostmenopausal Bone LossBreast Cancer
Dana-Farber Cancer Institute 50
Large-scale testing (Phase 3)Study completedNCT00670501
What this trial is testing

Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis, Postmenopausal
Eli Lilly and Company 1,637
Not applicableStudy completedNCT01416194
What this trial is testing

Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)

Who this might be right for
Osteoporosis, Postmenopausal
Pfizer 10,497
Large-scale testing (Phase 3)Study completedNCT00414973
What this trial is testing

Patients With Osteoporosis

Who this might be right for
Osteoporosis
Eli Lilly and Company 364
Post-approval studies (Phase 4)Study completedNCT00453492
What this trial is testing

Risedronate Sodium in Post Menopausal Osteoporosis

Who this might be right for
Osteoporosis, Postmenopausal
Sanofi 246
Not applicableUnknownNCT04760145
What this trial is testing

EFFECT OF FLOW RESTRICTION ON BONE QUALITY WITHIN A MULTICOMPONENT EXERCISE PROGRAM FOR OLDER WOMEN WITH OSTEOPOROSIS.

Who this might be right for
OsteoporosisOsteoporosis, PostmenopausalBone Diseases+1 more
Universitat Internacional de Catalunya 94
Testing effectiveness (Phase 2)Study completedNCT00238745
What this trial is testing

Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.

Who this might be right for
Postmenopausal Osteoporosis
Wyeth is now a wholly owned subsidiary of Pfizer 375
Not applicableStudy completedNCT04196426
What this trial is testing

Nutrition Education to Promote Calcium Intake Among 30-65 Year-old Women in Vietnam

Who this might be right for
Osteoporosis
Texas Tech University 250
Early research (Phase 1)Study completedNCT03822078
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women

Who this might be right for
Osteoporosis
Amgen 45
Early research (Phase 1)Study completedNCT01074723
What this trial is testing

B-cryptoxanthin and Phytosterols on Bone Remodeling and Cardiovascular Risk Factors

Who this might be right for
Postmenopausal Disorder
Puerta de Hierro University Hospital 36
Early research (Phase 1)Study completedNCT00417261
What this trial is testing

Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.

Who this might be right for
Healthy
Novartis 65
Large-scale testing (Phase 3)WithdrawnNCT01552122
What this trial is testing

Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)

Who this might be right for
OsteoporosisPostmenopausal Osteoporosis
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT00398931
What this trial is testing

FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)

Who this might be right for
Osteoporosis, Postmenopausal
Organon and Co 1,099
Early research (Phase 1)Study completedNCT01551602
What this trial is testing

Clinical Study of AK159 in Healthy Postmenopausal Women

Who this might be right for
Osteoporosis
Asahi Kasei Therapeutics Corporation 132
Not applicableStudy completedNCT00848159
What this trial is testing

Postural Assessment by Photogrammetry

Who this might be right for
Osteoporosis
Universidade de Franca 12
Not applicableStudy completedNCT03910348
What this trial is testing

Effects of Whole-Body Vibration and High Impact Exercises in Postmenopausal Women

Who this might be right for
Osteoporosis, PostmenopausalExercise Therapy
Istanbul University 58
Testing effectiveness (Phase 2)Study completedNCT00293813
What this trial is testing

A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density

Who this might be right for
Postmenopausal Osteoporosis
Amgen 247
Next Page